[b][CITY, January 29, 2015] – VENITI,[/b] the first medical company dedicated to providing technology for the treatment of venous disease, develops a wide range of comprehensive treatment across the venous disease field. With a team of experts in science, technology, and business, they are continuously engaged in the process of crafting a variety of products and technologies, including the new VENITI™ VICI™ Venous Stent System.

[b]Innovative Technologies for the Treatment of Venous Disease[/b]

VENITI aims to develop a range of innovative technologies to treat those suffering from venous disease and chronic leg ulcers. They are currently developing the VICI Venous Stent System, the first stent designed from inception for use in the venous system. The stent provides high crush resistant, end-to-end strength, and shape with flexibility and controlled deployment.

The product is currently available for use in the European Union. It has also received an IDE or Investigational Device Exemption approval in the United States. It is undergoing clinical trial procedures in the US, which involves 200 patients at a maximum of 30 investigational sites worldwide.

[b]Partnerships with Healthcare Professionals[/b]

VENITI is partnering with healthcare professionals for the evaluation and treatment of venous disease. According to the medical company, this relationship will allow them to offer the most innovative technologies and devices for venous disease treatments.

Medical device makers only provide partial solutions to physicians treating venous diseases. Because of this, VENITI aims to provide innovative devices that will provide complete solutions to physicians and enhance the treatment of various disorders in the venous state disease spectrum. This is evidenced by the clinical outcomes of the VICI Venous Stent System, which has demonstrated significant improvement in pain, swelling, and ulcer healing and substantial decrease in the venous severity and disability scores. The new technology has even become the primary treatment of venous outflow obstruction, surpassing bypass surgery.

[b]About VENITI[/b]

VENITI is the first medical device company dedicated to developing technology and solutions for the treatment of venous disease. Under the leadership of President and CEO Scott Solano, VENITI has become a company widely known to address challenges specific to the venous system. Their latest technology is the VICI Venous Stent, which is specifically designed for the treatment of adult patients suffering from systematic venous outflow obstruction.

Visit VENITI.com for more information about VENITI’s innovative technologies and solutions.